Latest News

Antipsychotic medications for schizophrenia compared: Similar results

Among adults with schizophrenia or schizoaffective disorder, treatment with the newer, more costly antipsychotic paliperidone palmitate, compared with the older antipsychotic haloperidol decanoate, found no significant difference on a measure of effectiveness, according to a recent study. Long-acting injectable antipsychotic medications are prescribed to reduce nonadherence to drug therapy and relapse in people diagnosed with a schizophrenia-spectrum disorder. The relative effectiveness of long-acting injectable versions of second-generation and older antipsychotic medications has not been previously assessed.
View full story

Post your comment.


  • Repeating aloud to another person boosts recall

  • American placebo: New analysis of chronic pain drug trials shows increasing placebo responses over time, in the US only

  • Understanding others' thoughts enables young kids to lie

  • Mutation involved in neurodegeneration discovered

  • How dominant parents affect kids' self-worth

  • Virus-drug combination shows improved effectiveness against brain tumor cells

  • Risk profiling is key to managing pain in era of opioid abuse

  • Benzodiazepines ineffective in treating anxiety disorders may increase dementia risk

  • Immigrants play increasing role in U.S. science, engineering workforce

  • Scientists identify how normally protective immune responses kill neurons